About 100 reports

  • Asthma Therapeutics Market, Global, Licensing Deals by Molecular Target, 2006-2016
  • Asthma Therapeutics Market, Global, Co-Development Deals by Molecular Target, 2006-2016
  • Cytokine
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG
  • Clinical Trial profile. 760 Trial Title
  • Clinical Trial profile. 206 Trial Title

CYTOKINE PRODUCTION IN COPD PATIENTS INVESTIGATION ON THE ROLE OF CORTICOSTEROIDS AND BETA-AGONISTS ON CYTOKINE PRODUCTION IN COPD PATIENTS GDCT## NCT##, COPD IL## RESPIRATORY CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) (CYTOKINE, INTERFERON GAMMA (IMMUNE INTERF

  • Cytokine
  • Hospital
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Interferon Major Producer and Their Market Share
  • IV

cytokines that were first seen to be expressed by white blood cells (leukocytes).

  • Cytokine
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Interleukin
  • Interferon Major Producer and Their Market Share (Million

cytokines that were first seen to be expressed by white blood cells (leukocytes).

  • Cytokine
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • C) Phase III
  • Rheumatoid Arthritis Market, Global, Pipeline, Clinical Trial Size by Mechanism

Upon stimulation of synoviocytes with pro-inflammatory cytokines, AP-## is activated, which induces the expression of many proteases and cytokines.

  • Arthritis
  • Cytokine
  • World
  • Market Size
  • Remicade group
  • Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Drug Profiles

The three Nimbus novel compounds, ND-##, ND-## and ND-## demonstrated high selectivity against a panel of ## kinases, and potent in vitro inhibition of cytokine production in cells and whole blood.

  • Autoimmune Disease
  • Cytokine
  • United States
  • World
  • Product Initiative
  • Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) Overview
  • Mechanism Of Action
  • Autoimmune Disease
  • Cytokine
  • World
  • Product Initiative
  • Novartis AG
  • CYTOSORB - CYTOKINE RELEASE SYNDROME - PRODUCT DESCRIPTION
  • CYTOSORB - CYTOKINE ADSORPTION IN SEPSIS AND ACUTE KIDNEY INJURY
  • Blood Supply
  • Clinical Trial
  • Cytokine
  • Therapy
  • GlobalData's company
  • Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drug Profiles
  • same indication granted in Europe in July 2012 from the European Commission.

IL-## is a member of the IL-##/ IL-## family of cytokines that signals through IL-##R ligation.

  • Cytokine
  • United States
  • World
  • Product Initiative
  • Cytheris SA
  • BNZ-1 - DRUG PROFILE
  • TILT-123 + TUMOR INFILTRATING LYMPHOCYTES - DRUG PROFILE

ZIOPHARM' s pipeline products include Ad-RTS-IL-## and CAR/ Cytokine Products.

  • Cytokine
  • Pharmaceutical
  • Prostate Cancer
  • Vaccine
  • OncBioMune Pharmaceuticals, Inc.
  • R&D Progress
  • Mechanism Of Action

IL-## is a cytokine, an immune system signaling molecule.

  • Cytokine
  • Digestive System Disorder
  • United States
  • World
  • Product Initiative
  • CV-18C3 - DRUG PROFILE
  • RA-18C3 - DRUG PROFILE

The excellent safety profile of MABp## demonstrated across multiple therapeutic indications to date, and strong initial results in this trial, provide the basis for further development of the first biologic therapy targeting the inflammatory cytokine IL-## alpha for acne treatment. ##-Oct-##

  • Cytokine
  • Europe
  • World
  • Product Initiative
  • XBiotech Inc.
  • Jyant Technologies, Inc. - Phase II, 2016
  • Jyant Technologies, Inc. - Pipeline by Target, 2016

Cytokine B##) Cyclin-Dependent Kinase ## (Tat-Associated Kinase Complex Catalytic Subunit or Cell Division Cycle ##-Like Protein Kinase ## or EC ##. ##. ##. ##) Source: Global Markets Direct Jyant Technologies, Inc. - Pipeline by Target, 2016 Atypical Chemokine Receptor ## (Chemokine Orphan Receptor

  • Cytokine
  • World
  • Litigation And Patent
  • Product Initiative
  • Jyant Technologies Inc
  • Interleukin 7 Receptor Subunit Alpha (CD127 or IL7R) - Drug Profiles
  • GSK-2618960 - DRUG PROFILE

The current study of safety and activity of CYT## treatment in genotype ## and ## patients resistant to one or multiple lines of SOC focuses on one of the more difficult segments of the HCV patient population and strongly supports the potential of additional studies with this cytokine. "

  • Cytokine
  • Therapy
  • United States
  • Product Initiative
  • Cytheris SA
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Discontinued Products
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) Overview
  • Cancer
  • Cytokine
  • United States
  • Product Initiative
  • ARMO Biosciences, Inc.
  • PIPELINE BY NEOVACS SA, H2 2016
  • SMALL MOLECULES TO INHIBIT IL-13 FOR ULCERATIVE COLITIS - DRUG PROFILE

Th## cytokine, interleukin (IL)-##, is the central regulator of the allergic diathesis.

  • Asthma
  • Cytokine
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • MDNA-209 - DRUG PROFILE
  • DAROMUN - DRUG PROFILE

L##-Interleukin-## (L##-IL##), consisting of the human antibody L## and the human cytokine IL-##.

  • Cytokine
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • RA-18C3 - DRUG PROFILE
  • Interleukin 1 Alpha (IL 1 Alpha or Hematopoietin 1 or IL1A) - Drug Profiles

IL-##a is a potent inflammatory cytokine that plays an important role in vascular inflammation and vascular smooth muscle proliferation.

  • Cytokine
  • Therapy
  • Europe
  • Product Initiative
  • XBiotech Inc.
  • Clinical Trial profile. 159 Trial Title
  • Clinical Trial profile. 33 Trial Title

Biogen, Inc. ## Jul 2001 ## Dec 2003 ## ## ## Interferon Alpha/ Beta Receptor ## (Cytokine Receptor Class II Member ## or Cytokine Receptor Family ## Member ## or Type I Interferon Receptor ## or IFNAR##) Agonist; Interferon Alpha/ Beta Receptor ## (Interferon Alpha Binding Protein

  • Cytokine
  • Cytokine Receptor
  • Neurological Disorder
  • Therapy
  • Biogen Idec Inc.
  • LY-3232094 - DRUG PROFILE
  • Interleukin 12 Receptor (IL12R) - Drug Profiles

Interleukin ## receptor is a cytokine receptor, binding interleukin ##.

  • Cytokine
  • Therapy
  • United States
  • Product Initiative
  • Neumedicines Inc.
  • DARLEUKIN - DRUG PROFILE

This targeted form of IL## yielded results similar to the untargeted cytokine, but at lower cumulative doses and more favorable treatment duration and schedule.

  • Cytokine
  • Therapy
  • World
  • Product Initiative
  • Biogen Idec Inc.
  • CM-101 - Drug Profile
  • Chronic Disease
  • Cytokine
  • World
  • Product Initiative
  • Pharmaxis Ltd

The drug candidate is a small recombinant protein that is a synthetic derivative of the human cytokine, interleukin-## (IL-##).

  • Cytokine
  • Therapy
  • United States
  • World
  • Product Initiative
  • CLINICAL TRIAL PROFILE SNAPSHOTS

A Parallel Double Blind Placebo Controlled Pilot Study The Effects of Atazanavir-induced Hyperbilirubinemia During Human Endotoxemia GDCT## NCT##, Infectious Disease Endotoxemia, Inflammation, Multiple Organ Failure, Sepsis (Cytokine, Lipopolysaccharide (Endotoxin)) Completed Pha

  • Biological Therapy
  • Cytokine
  • Infectious Disease
  • World
  • Product Initiative

When the drug candidate binds to the receptors, it blocks or modulates the actions of the cytokines responsible for neutrophil recruitment.

  • Chemokine
  • Cytokine
  • Therapy
  • Transplantation
  • Dompe Farmaceutici S.p.A.
  • CYTOSORB - CYTOKINE RELEASE SYNDROME
  • CYTOSORB - CYTOKINE ADSORPTION IN SEPSIS AND ACUTE KIDNEY INJURY
  • Cytokine
  • Therapy
  • United States
  • Demand
  • CytoSorbents Corporation
  • VACCINE TO TARGET INTERLEUKIN 4 AND INTERLEUKIN 13 FOR ALLERGIES - DRUG PROFILE
  • PIPELINE BY NEOVACS SA, H1 2016

Th## cytokine, interleukin (IL)-##, is the central regulator of the allergic diathesis.

  • Asthma
  • Cytokine
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Overview
  • ABY-035 - DRUG PROFILE

IL-## is a proinflammatory T-cell cytokine which is responsible for the production of other cytokines like IL-## and TNF-alpha.

  • Autoimmune Disease
  • Cytokine
  • United States
  • Product Initiative
  • Novartis AG

On the other hand, there was no effect on the production of helper ##-type cell derived cytokine (IL-## and IFN-gamma).

  • Chemokine
  • Cytokine
  • Lymphoma
  • Therapy
  • Kyowa Hakko Kirin Co., Ltd.

Cytokine & Chemokine Testing Chemokines Cytokines Enzyme-Linked Immunosorbent Assay (ELlSA) D.

  • Cytokine
  • Europe
  • Japan
  • United States
  • World